市場調査レポート

商品コード

1442597

インターベンショナル心臓デバイスの世界市場の評価：製品タイプ別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Interventional Cardiology Devices Market Assessment, By Product Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年03月04日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 225 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,420円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,532円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,285,432円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のインターベンショナル心臓デバイスの市場規模は、予測期間中にCAGR 8.37％で成長し、2023年の162億2,000万米ドルから、2031年には308億6,000万米ドルに成長すると予測されています。

心血管疾患の有病率の増加、心臓病デバイスの技術的進歩、規制当局の承認数の増加、高齢者人口の増加、心臓疾患や治療オプションに対する意識の高まり、医療支出の増加などの要因により、インターベンショナル心臓デバイスの市場は堅調な成長を示しています。心臓疾患の負担軽減、医療インフラの強化に向けた政府の取り組み、非営利医療団体からの寄付金なども同市場の成長にプラスの影響を与えています。

心臓デバイスにおける技術の進歩

インターベンショナル心臓デバイスの技術的進歩は近年著しいものです。こうした進歩には、ロボット技術、外科医が制御する小型手術ロボット、精度を高めるナビゲーションセンサー、バイオセンサーを備えたワイヤレス技術などの使用が含まれます。さらに、ロボットによる経皮的冠動脈インターベンション（PCI）技術においても、ワイヤー操作、ガイドカテーテル制御、IVUS画像処理などの改善が見られています。さらに、ワイヤレス技術やバイオセンサーは、モニタリングや診断などさまざまな用途に使用できるため、心臓インターベンションにおいて有望です。

心血管疾患の有病率の増加

心血管疾患は世界の主要死因であり、毎年1,790万人の命を奪っていると推定されています。人口の増加や高齢化などの要因により、心血管疾患の有病率は大幅に増加すると予想されています。心血管疾患患者の増加は、心血管疾患とリスク因子に関する既存の知識が実践に還元されていないことに起因しています。心血管疾患の負担は特に低・中所得国に重く、貧困の一因となり、経済的にも大きな負担となっています。不健康な食事、運動不足、タバコの使用、アルコール摂取は、心血管疾患のもっとも重要な行動学的リスク因子の1つです。心血管疾患の有病率の増加に伴い、インターベンショナル心臓デバイスに対する需要は大幅に増加すると予想されています。

北米が支配的地域に

北米はインターベンショナル心臓デバイスの主要地域になると予想されています。この地域は心血管疾患の有病率が高く、心臓デバイスに対する大きな需要につながっています。さらに、北米は低侵襲手術の採用率が高く、インターベンショナル心臓デバイス市場におけるトップメーカーの存在感も強いです。北米における医療支出の増加と可処分所得の高さも、市場における同地域の優位性に寄与しています。

当レポートでは、世界のインターベンショナル心臓デバイスの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

市場規模・予測
製品タイプ別
- ステント
- カテーテル
- バルーン
- シース
- バルブ
- 付属品・その他
エンドユーザー別
- 病院
- 外来手術センター
- 心臓クリニック
地域別
- 北米
- 欧州
- アジア太平洋
- 南米
- 中東・アフリカ
企業別市場シェア

第5章世界のインターベンショナル心臓デバイス市場の展望：地域別

北米
欧州
アジア太平洋
南米
中東・アフリカ

第6章市場マッピング

製品タイプ別
エンドユーザー別
地域別

第7章マクロ環境と産業構造

需要供給分析
輸出入分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進要因
成長抑制要因（課題・抑制要因）

第9章法規制の枠組み・イノベーション

臨床試験
特許環境
規制承認
イノベーション・新興技術

第10章主要企業の情勢

市場リーダー上位5社の競合マトリックス
市場リーダー上位5社の市場収益分析
M&A・ジョイントベンチャー (該当する場合)
SWOT分析 (参入5社)

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

Abbott Laboratories
Terumo Corporation
Teleflex Incorporated
B. Braun SE
Biosensors International Group
ACIST Medical Systems
Cook Medical
Merit Medical Systems
Boston Scientific Corporation
Medtronic plc

第14章戦略的提言

第15章当社について・免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 3. Global Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 4. Global Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 5. Global Interventional Cardiology Devices Market Share (%), By Region, 2017-2031F
Figure 6. North America Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 7. North America Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 8. North America Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 9. North America Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 10. North America Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F
Figure 11. United States Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 12. United States Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 13. United States Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 14. United States Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 15. Canada Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 16. Canada Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 17. Canada Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 18. Canada Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 19. Mexico Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 20. Mexico Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 21. Mexico Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 22. Mexico Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 23. Europe Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 24. Europe Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 25. Europe Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 26. Europe Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 27. Europe Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F
Figure 28. Germany Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 29. Germany Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 30. Germany Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 31. Germany Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 32. France Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 33. France Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 34. France Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 35. France Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 36. Italy Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 37. Italy Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 38. Italy Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 39. Italy Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 40. United Kingdom Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 41. United Kingdom Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 42. United Kingdom Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 43. United Kingdom Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 44. Russia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 45. Russia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 46. Russia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 47. Russia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 48. Netherlands Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 49. Netherlands Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 50. Netherlands Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 51. Netherlands Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 52. Spain Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 53. Spain Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 54. Spain Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 55. Spain Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 56. Turkey Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 57. Turkey Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 58. Turkey Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 59. Turkey Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 60. Poland Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 61. Poland Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 62. Poland Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 63. Poland Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 64. South America Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 65. South America Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 66. South America Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 67. South America Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 68. South America Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F
Figure 69. Brazil Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 70. Brazil Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 71. Brazil Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 72. Brazil Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 73. Argentina Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 74. Argentina Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 75. Argentina Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 76. Argentina Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 77. Asia-Pacific Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 78. Asia-Pacific Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 79. Asia-Pacific Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 80. Asia-Pacific Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 81. Asia-Pacific Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F
Figure 82. India Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 83. India Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 84. India Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 85. India Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 86. China Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 87. China Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 88. China Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 89. China Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 90. Japan Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 91. Japan Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 92. Japan Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 93. Japan Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 94. Australia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 95. Australia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 96. Australia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 97. Australia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 98. Vietnam Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 99. Vietnam Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 100. Vietnam Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 101. Vietnam Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 102. South Korea Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 103. South Korea Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 104. South Korea Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 105. South Korea Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 106. Indonesia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 107. Indonesia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 108. Indonesia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 109. Indonesia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 110. Philippines Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 111. Philippines Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 112. Philippines Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 113. Philippines Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 114. Middle East & Africa Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 115. Middle East & Africa Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 116. Middle East & Africa Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 117. Middle East & Africa Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 118. Middle East & Africa Interventional Cardiology Devices Market Share (%), By Country, 2017-2031F
Figure 119. Saudi Arabia Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 120. Saudi Arabia Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 121. Saudi Arabia Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 122. Saudi Arabia Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 123. UAE Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 124. UAE Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 125. UAE Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 126. UAE Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 127. South Africa Interventional Cardiology Devices Market, By Value, In USD Billion, 2017-2031F
Figure 128. South Africa Interventional Cardiology Devices Market, By Volume, in Million Units, 2017-2031F
Figure 129. South Africa Interventional Cardiology Devices Market Share (%), By Product Type, 2017-2031F
Figure 130. South Africa Interventional Cardiology Devices Market Share (%), By End-user, 2017-2031F
Figure 131. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 132. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 133. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11065

Global interventional cardiology devices market is projected to witness a CAGR of 8.37% during the forecast period 2024-2031, growing from USD 16.22 billion in 2023 to USD 30.86 billion in 2031. The interventional cardiology devices market is thriving due to factors like a growing prevalence of cardiovascular disorders, technological advancements in cardiology devices, an increasing number of regulatory approvals, a growing geriatric population, rising awareness about cardiac conditions and treatment options, and increasing healthcare expenditure. Government initiatives and contributions from non-profit medical organizations to reduce the cardiac disease burden and strengthen the healthcare infrastructure are some other factors positively impacting the interventional cardiology devices market growth.

However, the dominance of first-line alternative treatment options pushes back the demand for interventional cardiology devices. The high cost of surgical procedures and instruments used for cardiac surgery makes it the terminal choice for middle and lower-class patients. Alongside, risks associated with cardiac surgeries and interventional devices hinder the growth of this market.

In November 2023, Argon Medical Devices, a trusted provider of device solutions for interventional radiology, vascular surgery, interventional cardiology, and oncology, introduced the Kodiak Dual Port Coaxial Introducer Kit. This innovative kit enables precise and streamlined introduction of diagnostic and therapeutic devices into the vasculature, ensuring optimum results for patients.

Technological Advancements in Cardiology Devices

Technological advancements in interventional cardiology devices have been significant in recent years. These advancements include the use of robotic technologies, miniature surgical robots controlled by surgeons, navigational sensors for precision, and wireless technologies with biosensors. Additionally, advancements in robotic percutaneous coronary intervention (PCI) technology, including improvements in wire manipulation, guide catheter control, and IVUS imaging, have been observed. Furthermore, wireless technologies and biosensors hold promise for interventional cardiology, as they can be used for various applications such as monitoring and diagnosis. These advancements are enhancing the precision, safety, and effectiveness of interventional cardiology procedures, ultimately benefiting interventional cardiology devices. Key players are designing products with enhanced technologies to cater to the market needs.

In September 2023, Canon Medical launched the Alphenix Sky 12 HD interventional system with the new high-definition (Hi-Def) detector. The Alphenix Sky 12 HD features a 12"X12" Hi-Def detector to improve visualization for interventional procedures, including pediatric cases, in cardiology, neurology, oncology, and radiology.

Growing Prevalence of Cardiovascular Diseases

Cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. The prevalence of cardiovascular diseases is expected to increase substantially due to factors such as population growth and aging. The rise in cardiovascular disease cases is attributed to a lack of translation of existing knowledge about cardiovascular diseases and risk factors into practice. The burden of cardiovascular diseases is particularly heavy on low- and middle-income countries, where they contribute to poverty and place a significant economic strain. Unhealthy diet, physical inactivity, tobacco use, and alcohol consumption are among the most important behavioral risk factors for cardiovascular diseases. The demand for interventional cardiology devices is expected to increase significantly with the growing prevalence of cardiovascular diseases.

For instance, according to the World Heart Report 2023 published by the World Heart Federation, cardiovascular diseases have been the leading cause of death worldwide for many years. In 2021, more than 20 million people died from a cardiovascular condition, which accounted for about one-third of all global deaths. This figure is significantly higher than the 12.1 million cardiovascular disease deaths recorded in 1990. Ischemic heart disease is now the leading cause of premature death in 146 countries for men and 98 countries for women.

Dominance of Stents Segment

The stents segment is anticipated to be the leading segment in the interventional cardiology devices market. Stents are commonly used in interventional cardiology to treat coronary artery disease. They are expandable tubular metallic devices introduced into clogged coronary arteries, a procedure known as percutaneous coronary intervention (PCI) or coronary stenting. The most widely used stents are drug-eluting stents (DES), which have significantly reduced the incidence of restenosis in native stable coronary arteries. Stents have been shown to reduce angina and improve survival in patients with coronary artery disease. Innovative stent products from market players have significantly developed the market.

In October 2023, Medinol announced the United States Food and Drug Administration (FDA) approval for its EluNIR-PERL drug-eluting stent (DES), which is meant for the treatment of coronary artery disease. EluNIR-PERL has four radiopaque markers, two at each end, and a hybrid polymer-metal radiopaque catheter tip. These unique features allow excellent visualization during PCI procedures, whether navigating through complex anatomies or placing the stent precisely.

Ambulatory Surgical Centers to be the Fastest Growing End-user Segment

Cardiology procedures are increasingly being performed in ambulatory surgery centers (ASCs) due to various factors such as improved patient experiences, strong reimbursement rates, and cost savings. These procedures include the placement of pacemakers, loop recorders, AICD, diagnostic and interventional coronary procedures, peripheral vascular interventions, right and left heart catheterizations, coronary interventions, and defibrillator and pacemaker implants. The Centers for Medicare and Medicaid Services (CMS) support this shift to ASCs by adding cardiology procedures to the ASC-covered procedure list. This has led to a faster growth rate for ambulatory surgical centers. For instance, as per an article published by HMP Global in July 2023, around 2% of major cardiovascular procedures are being performed in ambulatory surgical centers and the traction is steadily rising.

North America to be the Dominating Region

North America is anticipated to be the leading region in interventional cardiology devices. The region has a high prevalence of cardiovascular diseases, leading to a significant demand for cardiology devices. Additionally, North America has a high adoption rate of minimally invasive procedures and a strong presence of top manufacturers in the interventional cardiology device market. The rising healthcare expenditure and high disposable incomes in North America also contribute to the dominance of the region in the interventional cardiology devices market. Alongside, prominent players in the interventional cardiology device market, such as Medtronic, Boston Scientific Corporation, and Abbott, have a strong presence in North America, further contributing to its dominance.

As per the American Heart Association, by 2035, almost 45% of the United States population is expected to experience heart disease due to unhealthy factors such as high obesity rates, smoking, and poor lifestyle choices. These factors may increase the risk of heart attacks and other related health issues.

Future Market Scenario (2024 - 2031F)

In recent years, notable regulatory emphasis has been helpful for novel marketed products. Several reforms have been made to speed up the approval process of interventional cardiology devices. The FDA has been granting several regulatory approvals for interventional cardiology devices. The classification of interventional cardiovascular implant simulation software devices has been updated to class II (special controls). Most class III devices require FDA approval of a PMA before they can be legally marketed. The classification of cardiovascular devices intended for human use that are in commercial distribution is outlined in 21 CFR Part 870. The number of cardiac device approvals for children seems to be growing, with most approvals being granted through the humanitarian device exemption (HDE) pathway.

In November 2023, Medtronic plc received approval from the United States Food and Drug Administration (FDA) for its Symplicity Spyral renal denervation (RDN) system, which is also known as the Symplicity blood pressure procedure. This system has been approved for use in treating hypertension. As a result of the approval, Medtronic will start the commercialization of the product right away. The device is mainly meant to reduce hypertension through relaxing nerves connected to the kidneys and reducing its activity.

Key Players Landscape and Outlook

The key players in the interventional cardiology devices market include Abbott Laboratories, Terumo Corporation, Teleflex Incorporated, and B. Braun SE, among others. Many companies are working on developing new products and expanding their business through collaborations, partnerships, mergers, and strategic alliances. The market value of these players is driven by the successful implementation of these strategies. Additionally, regulatory approvals for new products and services also contribute to the growth of both the players and the market.

In October 2023, Haemonetics offered USD 253 million for sensor equipped TAVR guidewire maker OpSens. The deal is expected to close in January 2024. Haemonetics is a Boston-based medical device maker, while OpSens is a Canadian developer of optical sensor-equipped devices for both medical and industrial uses.

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Interventional Cardiology Devices Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Product Type
- 4.2.1. Stents
  - 4.2.1.1. Bare-Metal Stents
  - 4.2.1.2. Drug-Eluting Stents
  - 4.2.1.3. Bio Absorbable Stent
  - 4.2.1.4. Others
- 4.2.2. Catheters
  - 4.2.2.1. Angiography Catheters
  - 4.2.2.2. Atherectomy Catheters
  - 4.2.2.3. Thrombectomy Catheters
  - 4.2.2.4. Ablation Catheters
  - 4.2.2.5. IVUS Catheters
  - 4.2.2.6. Others
- 4.2.3. Balloons
  - 4.2.3.1. PTCA Balloons
  - 4.2.3.2. Valvuloplasty Balloons
  - 4.2.3.3. Others
- 4.2.4. Sheaths
- 4.2.5. Valves
- 4.2.6. Accessories and others
4.3. By End-user
- 4.3.1. Hospitals
- 4.3.2. Ambulatory Surgical Centers
- 4.3.3. Cardiology Clinics
4.4. By Region
- 4.4.1. North America
- 4.4.2. Europe
- 4.4.3. Asia-Pacific
- 4.4.4. South America
- 4.4.5. Middle East and Africa
4.5. By Company Market Share (%), 2023

5. Global Interventional Cardiology Devices Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Product Type
  - 5.1.2.1. Stents
  - 5.1.2.1.1. Bare-Metal Stents
  - 5.1.2.1.2. Drug-Eluting Stents
  - 5.1.2.1.3. Bio Absorbable Stent
  - 5.1.2.1.4. Others
  - 5.1.2.2. Catheters
  - 5.1.2.2.1. Angiography Catheters
  - 5.1.2.2.2. Atherectomy Catheters
  - 5.1.2.2.3. Thrombectomy Catheters
  - 5.1.2.2.4. Ablation Catheters
  - 5.1.2.2.5. IVUS Catheters
  - 5.1.2.2.6. Others
  - 5.1.2.3. Balloons
  - 5.1.2.3.1. PTCA Balloons
  - 5.1.2.3.2. Valvuloplasty Balloons
  - 5.1.2.3.3. Others
  - 5.1.2.4. Sheaths
  - 5.1.2.5. Valves
  - 5.1.2.6. Accessories and others
- 5.1.3. By End-user
  - 5.1.3.1. Hospitals
  - 5.1.3.2. Ambulatory Surgical Centers
  - 5.1.3.3. Cardiology Clinics
- 5.1.4. United States*
  - 5.1.4.1. Market Size & Forecast
  - 5.1.4.1.1. By Value
  - 5.1.4.1.2. By Volume
  - 5.1.4.2. By Product Type
  - 5.1.4.2.1. Stents
  - 5.1.4.2.1.1. Bare-Metal Stents
  - 5.1.4.2.1.2. Drug-Eluting Stents
  - 5.1.4.2.1.3. Bio Absorbable Stent
  - 5.1.4.2.1.4. Others
  - 5.1.4.2.2. Catheters
  - 5.1.4.2.2.1. Angiography Catheters
  - 5.1.4.2.2.2. Atherectomy Catheters
  - 5.1.4.2.2.3. Thrombectomy Catheters
  - 5.1.4.2.2.4. Ablation Catheters
  - 5.1.4.2.2.5. IVUS Catheters
  - 5.1.4.2.2.6. Others
  - 5.1.4.2.3. Balloons
  - 5.1.4.2.3.1. PTCA Balloons
  - 5.1.4.2.3.2. Valvuloplasty Balloons
  - 5.1.4.2.3.3. Others
  - 5.1.4.2.4. Sheaths
  - 5.1.4.2.5. Valves
  - 5.1.4.2.6. Accessories and others
  - 5.1.4.3. By End-user
  - 5.1.4.3.1. Hospitals
  - 5.1.4.3.2. Ambulatory Surgical Centers
  - 5.1.4.3.3. Cardiology Clinics
- 5.1.5. Canada
- 5.1.6. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Product Type
6.2. By End-user
6.3. By Region

7. Macro Environment and Industry Structure

7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Abbott Laboratories
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products & Services
- 13.1.4. Financials (As reported)
- 13.1.5. Key Market Focus & Geographical Presence
- 13.1.6. Recent Developments
13.2. Terumo Corporation
13.3. Teleflex Incorporated
13.4. B. Braun SE
13.5. Biosensors International Group
13.6. ACIST Medical Systems
13.7. Cook Medical
13.8. Merit Medical Systems
13.9. Boston Scientific Corporation
13.10. Medtronic plc

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

インターベンショナル心臓デバイスの世界市場の評価：製品タイプ別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Interventional Cardiology Devices Market Assessment, By Product Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のインターベンショナル心臓デバイス市場の展望

第5章世界のインターベンショナル心臓デバイス市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章法規制の枠組み・イノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章当社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Interventional Cardiology Devices Market Outlook, 2017-2031F

5. Global Interventional Cardiology Devices Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

インターベンショナル心臓デバイスの世界市場の評価：製品タイプ別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Interventional Cardiology Devices Market Assessment, By Product Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のインターベンショナル心臓デバイス市場の展望

第5章 世界のインターベンショナル心臓デバイス市場の展望：地域別

第6章 市場マッピング

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 法規制の枠組み・イノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Interventional Cardiology Devices Market Outlook, 2017-2031F

5. Global Interventional Cardiology Devices Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のインターベンショナル心臓デバイス市場の展望

第5章世界のインターベンショナル心臓デバイス市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章法規制の枠組み・イノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章当社について・免責事項